HomeInsightsPE

Caplin Point Laboratories Ltd PE Ratio

Caplin Point Laboratories Ltd PE Ratio

stocks purchased

₹ 1.7 Cr

Volume transacted

stocks purchased

8.8 K

stocks traded

Last Updated time: 13 Oct 15:30 PM

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

PE

30.4

Last updated: 13 Oct 15:30 PM

Key Highlights

  • The P/E Ratio of Caplin Point Laboratories Ltd is 30.4 as of 13 Oct 15:30 PM.
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 17.2 on March 2019 to 21.9 on March 2024 . This represents a CAGR of 4.11% over 6 years. .
  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 1907 as of 11 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Caplin Point Laboratories Ltd

No data available

Company Fundamentals for Caplin Point Laboratories Ltd

No data available

Image

Caplin Point Laboratories Ltd

NSE: CAPLIPOINT

PRICE

1907.8

19.10 (1.01%)

stock direction

Last updated: 11 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Caplin Point Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 20241907.8
10 Oct 20241888.7
09 Oct 20241901.75
08 Oct 20241928
07 Oct 20241931
04 Oct 20241967.45
03 Oct 20242001.75
01 Oct 20242080.3
30 Sep 20241897.55
27 Sep 20241911.5

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Caplin Point Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Caplin Point Laboratories Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Caplin Point Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Caplin Point Laboratories Ltd

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16th, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

Caplin Point Laboratories Ltd News Hub

News

Volumes jump at Caplin Point Laboratories Ltd counter

BASF India Ltd, Blue Dart Express Ltd, KFin Technologies Ltd, Welspun Living Ltd are among...

Read more

01 Oct 202414:30

News

Caplin Point hits life high after Chennai unit clears Brazilian Agency's inspection

ANVISA conducted an inspection of Caplin Steriles' injectable and ophthalmic manufacturing...

Read more

19 Aug 202409:46

News

Caplin Point Laboratories Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, Godfrey Phillips India Ltd, Gravita India Ltd and Poly Medicure ...

Read more

19 Aug 202412:00

News

Volumes spurt at Caplin Point Laboratories Ltd counter

Hindustan Zinc Ltd, Godfrey Phillips India Ltd, Angel One Ltd, Triveni Engineering and Ind...

Read more

19 Aug 202414:30

News

Caplin Point Chennai unit clears Brazilian Agency's inspection

Caplin Point Laboratories informed that ANVISA conducted an inspection of Caplin Steriles'...

Read more

17 Aug 202417:07

News

Board of Caplin Point Laboratories recommends final dividend

Caplin Point Laboratories announced that the Board of Directors of the Company at its meet...

Read more

07 Aug 202416:31

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Caplin Point Laboratories Ltd

What is the current PE Ratio of Caplin Point Laboratories Ltd?

The Current PE Ratio of Caplin Point Laboratories Ltd is 30.36 as on 13 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Oct 2024.

What was the PE Ratio of Caplin Point Laboratories Ltd last year?

The PE Ratio of Caplin Point Laboratories Ltd was 12.04 last year, now the PE ratio is 30.36, showing a year-on-year growth of 152.2%.

What does the PE Ratio of Caplin Point Laboratories Ltd indicate about its stock?

The PE Ratio of Caplin Point Laboratories Ltd is 30.36. This ratio indicates that investors are willing to pay 30.36 times the earnings per share for each share of Caplin Point Laboratories Ltd.

What is the PE Ratio Growth of Caplin Point Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Caplin Point Laboratories Ltd grew by 152.2% whereas, the EPS ratio grew by 1.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*